Duration Of Testosterone Suppression And The Risk Of Death From Prostate Cancer In Men Treated Using Radiation And 6 Months Of Hormone Therapy (p NA)

UroToday.com- Dr. Anthony D’Amico and colleagues report in Cancer, that the duration of testosterone (androgen) suppression (AS) following androgen deprivation therapy (ADT) in combination with radiotherapy is associated with the risk of prostate cancer-specific mortality (PCSM) and all-cause mortality (ACM). The study was partially based upon the knowledge that older men have a longer time to return serum testosterone levels to noncastrate levels as compared to younger men. [click link for full article]

More: continued here

Filed under: Prostate on November 11th, 2007